Harnessing the Power of Data With Life Science Analytics MedTRACK

MedTRACK is a fully integrated research and information resource that can track the product pipeline progression of nearly 5,000 global companies by therapeutic indication, product and trial details, as well as the financial information of those companies that are publicly traded. The database is designed to enable industry professionals to look at public and private companies that are working in a particular areas of core business and quickly determine where they rank clinically as well as financially. In addition, MedTRACK provides extensive research tools that allow you to customize your queries; select individualized search criteria, merge information on the financial statements and pipelines of two or more companies, and conduct searches of companies and their respective products by geography, mechanism of action, or by patent expiration.

(PRWEB) December 21, 2003 --Are you interested in knowing which companies have Phase III products and less than one year of cash remaining? Would you like to see a side-by-side comparison of the clinical trial stages of companies conducting research on prostate cancer and be able to sort these companies by variables such as years in cash, cash on hand, market cap, and stage of development? Would your decision-making abilities be improved by knowing which pharmaceutical patents will expire in the next three years? Life Science Analytics (LSA) has developed MedTRACK, a Web-based biomedical intelligence database that provides the answers to these questions and more to executives and professionals in the pharmaceutical and biotechnology industries.

MedTRACK is a fully integrated research and information resource that can track the product pipeline progression of more than 4,500 global companies by therapeutic indication, product and trial details, and financial information. The database is designed to enable industry professionals to look at public and private companies that are working in a particular therapeutic area and quickly determine where they rank clinically as well as financially. In addition, MedTRACK provides extensive research tools that allow you to customize your enquiries; select individualized search criteria, merge information on the financial statements and pipelines of two or more companies, and conduct searches of companies and their respective products by geography, mechanism of action, or by patent expiration.

The main MedTRACK database product incorporates many features and resources. The Disease Hub organizes company information according to area of research and product development. Choose from 17 specific disease categories and more than 800 subcategories, including cancer, cardiovascular and circulatory system, genetic diseases and dysmorphic syndromes, and respiratory and pulmonary system, and view pipeline and financial data, stock quotes, a business description, product summaries and details, corporate trademarks, corporate partners and officers, and more. Click on the companys ticker symbol for a MedTRACK Quote" that displays share price and volume, market cap, cash on hand and years in cash, various financial ratios, financial statements, and an interactive stock history chart. Other specialized features display recent updates, chart and table representations of each firms product pipeline, and more. The Industry Hub organizes data into 38 industry categories (biotechnology/biopharmaceutical, gene/cell therapy, pharmaceuticals, etc), further divided into more than 100 subcategories, and displays current and important information for each company listed, including key financial data, and valuation and growth ratios. Other features include a Global Companies Hub that provides similar information on international private and public companies, a regularly updated news ticker, customizable company report options, the Company Explorer section that lets you track firms based on 18 different parameters, and a Drug Patent Expiry database searchable by patent and market exclusivity expiration dates, active ingredient, product name, and company name. The Merger Tool combines pipeline and financial information for two or more companies, facilitating research. Finally, subscribers can use the Geographical Search tool to explore and investigate companies based on their geographical location, and also access the Report Center to order preprepared company reports.

Subscribers can also choose to upgrade to MedTRACKs Premium Services. MedTRACK Analytics defines a set of metrics that evaluates a company compared to its competitors as well as a broader industry index." Subscribers can access a unique ranking system that combines 35 analytical measurements into six metric classes, including Pipeline Metrics, which represents an evaluation and comparison of a companys pipeline to a representative group of competitors and a related index. The final scores for each metric are weighted and combined into a global LSA Index that reflects the overall assessment of the company. Select from data into an Industry Index (Amex Pharma, Emerging Biotech Index, etc), competitive analysis of specific companies, and preprepared company reports. Subscribers may also request custom company reports if one does not already exist in the database. MedTRACK has also identified research scientists and physicians from leading academic institutions, community physicians responsible for new product implementation, consultants, and regulatory, marketing, and industry specialists that are available, through MedTRACK Advisors, for telephone and instant messenger consultations, roundtable discussions or to serve as ad hoc advisors on a regular basis. LSA will "identify the Advisors and arrange for the opportunity to gain key insight into new products, underlying mechanisms of action, regulatory hurdles, marketing obstacles, physician and customer acceptance as well as undertaking industry surveys."

"We have found MedTRACK to be an invaluable asset in conducting a wide range of corporate activities, including intelligence and business development. MedTRACK provides powerful, yet intuitive, search tools that allow rapid identification of companies of interest, including information on their drugs in development and clinical trials, as well as detailed financials."
Alex McPherson, MD, PhD, President and CEO, Biomira Inc

"Life Science Analytics Inc. strives to stay ahead of its competitors by using cutting-edge database structures", says Nadia Dailey, Executive Vice-President. "The system is updated on a daily basis through the latest advances in programming, allowing company executives, analysts, bankers, consultants, and investors to use Life Science Analytics Web-based MedTRACK research database system and unique interface to get the most up-to-date financial and analytical information on companies in the health care and biomedical industries. We are at the forefront of the pharmaceutical data collection industry. We collect comprehensive financial, company, and pipeline information and combine it with an easy-to-use front end interface that really enables our subscribers to quickly and efficiently find the data they need; no other system can match our package of authoritative content and intuitive, user-friendly data display."

The database was designed and created in 1998 and was launched as a subscription-based product in March 2003. Ms. Dailey notes that even though the current format is the result of more than one year of research, design work, and testing, Life Science Analytics is by no means resting on its laurels; the company continues to plan and roll out new products and features for subscribers. For a demonstration of MedTRACK, visit www.medtrack.com.